Friday, 6 December 2019

Reuters Health Report: WHO decries 'collective failure' as measles kills 140,000

Reuters.com Newsletter

WHO decries 'collective failure' as measles kills 140,000

Measles infected nearly 10 million people in 2018 and killed 140,000, mostly children, as devastating outbreaks of the viral disease hit every region of the world, the World Health Organization said on Thursday.

FDA probes diabetes drug metformin for carcinogen NDMA

The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year.

North Korea to launch medical tourism, targeting visitors from China

North Korea, one of the world's most reclusive states, plans to branch out into medical tourism next year, offering foreign visitors, most likely from China, treatments including cataract surgery, dental implants and therapy for tumors.

New York doctor convicted of taking kickbacks from opioid maker Insys

A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys Therapeutics Inc in exchange for prescribing his patients an addictive fentanyl spray the drug manufacturer produced.

Biogen builds case for its Alzheimer's drug, skeptics say more data needed

Biogen Inc on Thursday laid out more data on its experimental Alzheimer's drug that raised no major safety alarms but also offered little compelling evidence the drug, once declared a failure, actually works.

One in three U.S. high schools have no athletic trainers

(Reuters Health) - One in every three high schools in the U.S. has no access to an athletic trainer, according to a large study.

Rural hospital acquisitions may reduce patient services

(Reuters Health) - Although hospitals can improve financially when they join larger health systems, the merger may also reduce access to services for patients in rural areas, according to a new study.

U.S. FDA approves generic versions of Novartis blockbuster MS treatment

The U.S. Food and Drug Administration on Thursday approved three generic versions of Swiss drugmaker Novartis AG's top-selling multiple sclerosis (MS) medicine Gilenya.

U.S. health spending recovers after two slow years: CMS

U.S. healthcare spending recovered in 2018 after two consecutive years of decline, a government health agency reported on Thursday.

Many doctors in training may skip routine health care

(Reuters Health) - Trainee doctors often miss out on routine medical care and preventive health services even when they take daily prescriptions, a small study suggests.

Hairdressers' skin damaged by hair dyes

(Reuters Health) - Hairdressers may have skin damage from a hair dye ingredient even when they don't have dermatitis, or rashes, from this exposure, a small lab experiment suggests.

Related Videos

Vogue's Wintour: Cherish clothes then pass them on

Swift takes high road, makes history, at AMAs

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS